{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4592"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Public Health Service Act to improve the diagnosis and treatment of hereditary\n\t\t\t hemorrhagic telangiectasia, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140507", "#text": "May 7, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Ways and Means"}], "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Gerlach", "@name-id": "G000549"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Himes", "@name-id": "H001047"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H80D6ED2C7FA740D2ACC8027706E69C58", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HCD2ED1A1984D4A3DABF0F93AB224E135"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds as follows:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Hereditary hemorrhagic telangiectasia (HHT) is a largely undiagnosed or misdiagnosed vascular\n\t\t\t genetic bleeding disorder resulting in artery-vein malformations (AVMs)\n\t\t\t which lead to preventable catastrophic and disabling consequences. HHT can\n\t\t\t cause sudden death at any age, unless detected and treated. Early\n\t\t\t detection, screening, and use of readily available treatment can prevent\n\t\t\t premature deaths and long-term health complications resulting from HHT. A\n\t\t\t person with HHT has the tendency to form blood vessels that lack the\n\t\t\t capillaries between an artery and vein. HHT often results in spontaneous\n\t\t\t hemorrhage or stroke from brain or lung AVM. In addition to hemorrhagic\n\t\t\t stroke, embolic stroke and brain abscess occur in approximately 30 percent\n\t\t\t of persons with HHT artery-vein malformations in the lung (due to lack of\n\t\t\t capillaries between the arterial and venous systems which normally filter\n\t\t\t out clots and bacteria)."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HB626B49334E54240A468CCF389C291AA", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "One in 5,000 American children and adults suffer from HHT."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HD3BD7AFEFA9B4E62A871365A4BEB0711", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Studies have found an increase in morbidity and mortality rates for individuals who suffer from\n\t\t\t HHT."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "H553F71643DB84AB0A04F4BCB4B5E92D6", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Due to the widespread lack of knowledge, accurate diagnosis, and appropriate intervention, 90\n\t\t\t percent of HHT-affected families are at risk for preventable\n\t\t\t life-threatening and disabling medical incidents such as stroke."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H55C8B25FBB7C46A1B5BC84F3A3FEAEDF", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Early detection, screening, and treatment can prevent premature deaths, spontaneous hemorrhage,\n\t\t\t hemorrhagic stroke, embolic stroke, brain abscess, and other long-term\n\t\t\t health care complications resulting from HHT."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HF5B4C76FA4184EB9BEA5171BB9851E2D", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "HHT is an important health condition with serious health consequences which are amenable to early\n\t\t\t identification and diagnosis with suitable tests, and acceptable and\n\t\t\t available treatments in established treatment centers."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "HDB37DE2148A5419F8A278B4B7C921F1D", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Timely identification and management of HHT cases is an important public health objective because\n\t\t\t it will save lives, prevent disability, and reduce direct and indirect\n\t\t\t health care costs expenditures. A recent study has found use of a genetic\n\t\t\t testing model for HHT diagnosis saves $9.9 million in that screening can\n\t\t\t be limited to those persons within the family groups who actually have the\n\t\t\t gene defect, leading to early intervention in those found to have\n\t\t\t treatable AVMs."}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "H463B6AC591F347A9BA25EC43CD0AEB89", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Without a new program for early detection, screening, and treatment, 14,000 children and adults who\n\t\t\t suffer from HHT in the population today will suffer premature death and\n\t\t\t disability."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "HC6A449391F174E588F847C6F6650EBDB", "#text": "\n        "}], "#text": "\n      ", "@id": "H0E934656BD6048C59DCE9DA92B8B2AEB"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t", "#text": "The purpose of this Act is to create a federally led and financed initiative for early diagnosis\n\t\t\t and appropriate treatment of hereditary hemorrhagic telangiectasia that\n\t\t\t will result in the reduction of the suffering of families, prevent\n\t\t\t premature death and disability, and lower health care costs through proven\n\t\t\t treatment interventions.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Purpose"}, "#text": "\n      ", "@id": "HF422576E9FCB48EB879FBA799C9DB694"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by inserting after ", "@entity-type": "act", "#text": "Part B of title III of the Public Health Service Act", "@value": "Public Health Service Act/t:III/pt:B"}, "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 317T", "@value": "Public Health Service Act/s:317T"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 247b\u201322", "@value": "usc/42/247b\u201322"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Centers for disease control and prevention"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "317U."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Hereditary hemorrhagic telangiectasia"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": [{"#tail": "), the ", "#text": "HHT"}, {"#tail": ") shall carry out the following activities:", "#text": "Director"}], "#text": "With respect to hereditary hemorrhagic telangiectasia (in this section referred to as ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (in this section referred to as\n\t\t\t the ", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control and Prevention", "@entity-id": "7523"}}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Public Health Service Act/s:317U/ss:c", "@proposed": "true"}, "#text": "The conduct of population screening described in "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HEDDD7AACDD5C46E6AA428E187BF3A515", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The identification and conduct of investigations to further develop and support guidelines for\n\t\t\t diagnosis of, and intervention for, HHT, including cost-benefit studies."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HB729D85E6F7146F09CA11A4E640E0AF2", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The development of a standardized survey and screening tool on family history."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H3F636A85980146809A4F22505F43A80C", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to provide comprehensive education on, and disseminate\n\t\t\t information about, HHT to health professionals, patients, industry, and\n\t\t\t the public.", "@entity-type": "federal-body", "#text": "Centers for Disease Control and\n\t\t\t Prevention", "@entity-id": "7523"}, "#text": "The establishment, in collaboration with a voluntary health organization representing HHT families,\n\t\t\t of an HHT resource center within the "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "H511C042A9CC64FA29190F151428C602F", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The conduct or support of public awareness programs in collaboration with medical, genetic, and\n\t\t\t professional organizations to improve the education of health\n\t\t\t professionals about HHT."}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "@id": "H47DF228DD3CB42C9A6CFBC4F4F6FF7F1", "#text": "\n              "}], "#text": "\n            ", "@id": "H9924418FDA3A488E8E7239CE0D292481"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall carry out this section through collaborative approaches within the National\n\t\t\t Center on Birth Defects and Developmental Disabilities and the Division\n\t\t\t for Heart Disease and Stroke Prevention of the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7523"}, {"#tail": " for clotting and bleeding disorders.", "@entity-type": "federal-body", "#text": "Centers for Disease Control\n\t\t\t and Prevention", "@entity-id": "7523"}], "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Collaborative approaches"}, "#text": "\n            ", "@id": "HF32EB29B5A4548B49DE1BCFFAE36D98C"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Public Health Service Act/s:317U/ss:a/p:1", "@proposed": "true"}, {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7523"}], "#text": "In carrying out population screening under "}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Population screening"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "designate and provide funding for a sufficient number of HHT Treatment Centers of Excellence to\n\t\t\t improve patient access to information, treatment, and care by HHT experts;"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HA735EBA808EA40E296E303F54CCC7BA9", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "conduct surveillance by means of a population study, supplemented by sentinel health care provider\n\t\t\t or center surveillance, and by administrative database analyses as useful,\n\t\t\t to accurately identify\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H00354650F8AA4A938AA4AB15365DAE3D", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the prevalence of HHT; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H9EAC75A5D7BF4703BCF653EA5ACA0446", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the prevalence of hemorrhagic and embolic stroke, and brain abscess, resulting from HHT;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HF89EAFDDDB9148ACB271332C2A287EA0", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in order to screen a\n\t\t\t broader population and more accurately determine the prevalence of HHT;", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}, "#text": "include HHT screening questions in the Behavioral Risk Factor Surveillance System survey conducted\n\t\t\t by the "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H8A10411FC97A4E989AF67C125408BFBA", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the Paul Coverdell National Acute Stroke Registry\n\t\t\t to facilitate\u2014", "@entity-type": "act", "#text": "paragraph (2)(B)", "@value": "Public Health Service Act/s:317U/ss:c/p:2/sp:B", "@proposed": "true"}, "#text": "provide data collected under "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "#text": "\n              ", "@id": "H16EFE87744594C66BC5410D6EEDDA0BA", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "analyses of the natural history of hemorrhagic and embolic stroke in HHT; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H7F326CABA2434C13B8C9F9ACAA5E3EC2", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "development of screening and artery-vein malformation treatment guidelines specific to prevention\n\t\t\t of complications from HHT;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H7EBD761464B24F3AB88B515ECAC9220F", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "develop and implement programs, targeted for physicians and health care professional groups likely\n\t\t\t to be accessed by families with HHT, to increase HHT diagnosis and\n\t\t\t treatment rates through the\u2014"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "#text": "\n              ", "@id": "H43B7AFEA6D8844F5930CE0564C309B23", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " through the creation of a database of patients assessed at such HHT\n\t\t\t Treatment Centers of Excellence (including with respect to phenotype\n\t\t\t information, genotype information, transfusion dependence, and\n\t\t\t radiological findings);", "@entity-type": "act", "#text": "paragraph\n\t\t\t (1)", "@value": "Public Health Service Act/s:317U/ss:c/p:1", "@proposed": "true"}, "#text": "establishment of a partnership with HHT Treatment Centers of Excellence designated under "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HD02CB191CEC742018E04087847D4736A", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "integration of such database with\u2014"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the universal data collection system used by the Centers for monitoring hemophilia with the blood\n\t\t\t disorders; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HEB10976E381242729DFB8A5E61B0D5BA", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the Paul Coverdell National Acute Stroke Registry; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H67E2BC3A5D6247ABB06158F980FB0C41", "#text": "\n                  "}], "#text": "\n                ", "@id": "H49535F09D3084CC98B6BD2B6BED022D0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "inclusion of other medical providers who treat HHT patients; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H2F82ABA0CE3C43F1AF721672C3CBA6FD", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "use existing administrative databases on non-HHT Treatment Centers of Excellence patients\u2014"}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "#text": "\n              ", "@id": "H6EDBB09E144245869E55D05C1305858C", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to learn about the natural history of HHT and the efficacy of various treatment modalities; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H6F013FD0CA0041C0BD5D38E3AFF034A6", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to better inform and develop screening and treatment guidelines associated with improvement in\n\t\t\t health care outcomes, and research priorities relevant to HHT."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H597C26BD4BB246EBB3AC5D085D51BCA7", "#text": "\n                "}]}], "#text": "\n            ", "@id": "H3F7D6222090841069B5C58FF3EB8088C"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (c)(1)", "@value": "Public Health Service Act/s:317U/ss:c/p:1", "@proposed": "true"}, {"#tail": " may designate, as an HHT Treatment Center of\n\t\t\t Excellence, academic health centers demonstrating each of the following:", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7523"}], "#text": "In carrying out "}, "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n            ", "#text": "Eligibility for designation as an HHT treatment center of excellence"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The academic health center possesses a team of medical experts capable of providing comprehensive\n\t\t\t evaluation, treatment, and education to individuals with known or\n\t\t\t suspected HHT and their health care providers."}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H92C1EA34814A4C5A82D51B503D729EBD", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The academic health center has sufficient personnel with knowledge about HHT, or formal\n\t\t\t collaboration with one or more partnering organizations for personnel or\n\t\t\t resources, to be able to\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H3AEB9DA376D9465C8F3FB51C90AB7077", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "respond in a coordinated, multidisciplinary way to patient inquiries; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HBB218366EC1C49D68CFCDC5EB7215FA9", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "coordinate evaluation, treatment, and education of patients and their families in a timely manner."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H886F6F2E44A54F968C30E27DB3B35436", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The academic health center has the following personnel, facilities, and patient volume:"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "#text": "\n              ", "@id": "H64B3C5A4C16A43599F9605FDFFE7D6B2", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A medical director with\u2014"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "specialized knowledge of the main organ manifestations of HHT; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HE298B8CAA8E14FF49E706A5EB5802BEB", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the ability to coordinate the multidisciplinary diagnosis and treatment of patients referred to the\n\t\t\t center."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HEFE70D93822546D4890538CD1D7AD1D5", "#text": "\n                  "}], "#text": "\n                ", "@id": "HB31DB0811E1E4B6BAECD33A61DD4AA31"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Administrative staff with\u2014"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "sufficient knowledge to respond to patient inquiries and coordinate patient care in a timely\n\t\t\t fashion; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H1F5D35C2DB2B495EB0FAFA34B5BC48AF", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "adequate financial support to allow the staff to commit at least 25 to 50 percent of their time on\n\t\t\t the job\n\t\t\t to HHT."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H8A4314C52D6843CBA5355E75645F2163", "#text": "\n                  "}], "#text": "\n                ", "@id": "HBC8EA27E05EC40A1B4924F39BD15CF53"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An otolaryngologist with experience and expertise in the treatment of recurrent epistaxis in HHT\n\t\t\t patients."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HC3192447C2984F08AB8AD1A3708A558C", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An interventional radiologist with experience and expertise in the treatment of pulmonary\n\t\t\t arteriovenous malformations (AVM)."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H2C986887042B4617B061AEA6C37D0555", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A genetic counselor or geneticist with the expertise to provide HHT-specific genetic counseling to\n\t\t\t patients and families."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "HF5C9FEE3E2DC4268BBD64F0515F1AE01", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "On-site facilities to screen for all major organ manifestations of HHT."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "H80E4C665460A42AD8F6F1BD2AAF13B5E", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A patient volume of at least 25 new HHT patients per year."}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "HEF6466340EDF43AC8EC5E844BB21FC1D", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "Established mechanisms to coordinate surveillance and outreach with HHT patient advocacy\n\t\t\t organizations."}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "H8BF21345B10446859A7D41051DB45A9F", "#text": "\n                "}]}], "#text": "\n            ", "@id": "H80F55E8BB6B44AD7807E21D136646946"}], "#text": "\n          ", "@id": "H4DE8D58DAD2744BAA02BBB7E97CCC28D"}, "#text": "\n\t\t\t\t", "@id": "H341A309E1CDD4D5F8CFAF9706CCE4C74"}, "#text": "\n      ", "@id": "H32496CD71F584380A0D814C111B9B27D"}, {"#tail": "\n    ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ", shall award grants on a competitive basis\u2014", "@entity-type": "federal-body", "#text": "Administrator of the Centers for\n\t\t\t Medicare & Medicaid Services", "@entity-id": "7530"}], "quote": {"#tail": "), the ", "#text": "HHT"}, "#tail": "\n\t\t\t", "#text": "With respect to hereditary hemorrhagic telangiectasia (in this section referred to as ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Additional health and human services activities"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or enrolled under ", "@entity-type": "act", "#text": "part A of\n\t\t\t title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII/pt:A"}, {"#tail": "; and", "@entity-type": "act", "#text": "part B of such\n\t\t\t title", "@value": "Social Security Act/t:XVIII/pt:B"}], "#text": "for an analysis by grantees of the Medicare Provider Analysis and Review (MEDPAR) file to develop\n\t\t\t preliminary estimates from the Medicare program under title XVIII of the\n\t\t\t Social Security Act for preventable costs of annual health care\n\t\t\t expenditures including items, services, and treatments associated with\n\t\t\t untreated HHT furnished to individuals with HHT, as well as socioeconomic\n\t\t\t costs such as disability expenditures associated with preventable medical\n\t\t\t events in this population, who are entitled to benefits under "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H0FD2066BF7BB4342A497F78B45D7EBE3", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014/s:5/p:1", "@proposed": "true"}, "#text": "to make recommendations regarding an enhanced data collection protocol to permit a more precise\n\t\t\t determination of the total costs described in "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H72EE7D12F2B64456A9CC16E88BEC5DA4", "#text": "\n        "}], "#text": "\n      ", "@id": "HBBD102F8CD5540209CB07CD1D1AB862B"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at\n\t\t\t the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Part B of title IV of the Public Health Service Act", "@value": "Public Health Service Act/t:IV/pt:B"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "42 U.S.C. 284 et seq.", "@value": "usc/42/284/etseq"}, "@parsable-cite": "usc/42/284", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "National institutes of health"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "409K."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Hereditary hemorrhagic telangiectasia"}, "subsection": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "HHT initiative"}, "paragraph": [{"#tail": "\n            ", "@id": "H962F3F982939458DA4AD2CDD6B65573B", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Establishment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall establish and implement an HHT initiative to assist in coordinating activities\n\t\t\t to improve early detection, screening, and treatment of people who suffer\n\t\t\t from HHT. Such initiative shall focus on\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "advancing research on the causes, diagnosis, and treatment of HHT, including through the conduct or\n\t\t\t support of such research; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H6A2F22002371495696C6FA815514ABB2", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "increasing physician and public awareness of HHT."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H41FCA612569F4B8F8CA62D1E9A2068CF", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall consult with the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "federal-body", "#text": "Director of the National\n\t\t\t Institutes of Health", "@entity-id": "7529"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control\n\t\t\t and Prevention", "@entity-id": "7523"}], "#text": "In carrying out this subsection, the "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Consultation"}, "#text": "\n              ", "@id": "HB5116379FB95464F807F4303D782E8F5"}], "#text": "\n            ", "@id": "H47A8ECA6B4C6444FAE3C32AF6FDF314C"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "HHT coordinating committee"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in\n\t\t\t consultation with the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall\n\t\t\t establish a committee to be known as the ", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Health", "@entity-id": "7529"}, {"@proposed": "true", "#tail": ".", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "HHT Coordinating Committee"}], "#text": "Not later than 60 days after the date of the enactment of this section, the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Establishment"}, "#text": "\n              ", "@id": "HD8909E38E820418BBAE42BFC5F35E364"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 317U(c)(1)", "@value": "Public Health Service Act/s:317U/ss:c/p:1", "@proposed": "true"}, "#text": "Four representatives of HHT Treatment Centers of Excellence designated under "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HC118065C759D4B81AEE5548027D42181", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Four experts in vascular, molecular, or basic science."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H1DC884DC47284948926EBA649E20723E", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}, "#text": "Four representatives of the "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "H05E065C7705E4E429B997CCAB2856187", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall be appointed by the ", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Committee"}, {"#tail": ", in consultation with the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and shall consist of 12 individuals\n\t\t\t who are experts in HHT or arteriovenous malformation (AVM) as follows:", "@entity-type": "federal-body", "#text": "Director\n\t\t\t of the National Institutes of Health", "@entity-id": "7529"}], "#text": "The members of the "}, "#text": "\n                ", "@id": "H2D0127A9AEA045539E50E54E028797D8"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall designate the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " from among its members.", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Chair of the Committee"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Chair"}, "#text": "\n                ", "@id": "H9AF8B69DBA4847FAA8CF4C522B39E02A"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the\n\t\t\t ", "@entity-type": "act", "#text": "subparagraph (A)(i)", "@value": "Public Health Service Act/s:409K/ss:b/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " may appoint 4 experts in vascular, molecular, or basic science\n\t\t\t to serve as members of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " during the period preceding\n\t\t\t designation and establishment of HHT Treatment Centers of Excellence under\n\t\t\t ", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Committee"}, {"#tail": ".", "@entity-type": "act", "#text": "section 317U", "@value": "Public Health Service Act/s:317U", "@proposed": "true"}], "#text": "In place of the 4 members otherwise required to be appointed under "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Interim members"}, "#text": "\n                ", "@id": "H48606B2EAEB8474296EC3FBAF6D7D41B"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": ", the ", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Committee"}, {"#tail": " shall publish the\n\t\t\t names of the Chair and members of the Committee on the Website of the\n\t\t\t Department of Health and Human Services.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 30 days after the establishment of the "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Publication of names"}, "#text": "\n                ", "@id": "HDFA42E235BCF4D20B7EF5940C8696F28"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall each be appointed for a 3-year term and, at the end of each such\n\t\t\t term, may be reappointed.", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Committee"}, "#text": "The members of the "}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "header": {"#tail": "\n                ", "#text": "Terms"}, "#text": "\n                ", "@id": "HBE4A511B04DE405C920A764A45F0FD2C"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall be filled by the ", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Committee"}, {"#tail": " in the same manner in which the\n\t\t\t original appointment was made.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A vacancy on the "}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "header": {"#tail": "\n                ", "#text": "Vacancies"}, "#text": "\n                ", "@id": "H9E07BC8CB6C04274A3F929AAF4FDDDEE"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Membership"}, "#text": "\n              ", "@id": "HC64C43D348D445E386FC9B8ACA3A5ED2"}, {"#tail": "\n          ", "@id": "H096A8FBDDE7747EEA735B1367B25431A", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Responsibilities"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall develop and coordinate implementation of a plan to advance research and\n\t\t\t understanding of HHT by\u2014", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "Committee"}, "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", including the ", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}, {"#tail": "; the ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National Heart, Lung, and\n\t\t\t Blood Institute", "@value": "National Heart, Lung, and Blood Institute"}, {"#tail": "; the ", "@entity-type": "federal-body", "#text": "National Institute of Neurological Disorders and\n\t\t\t Stroke", "@entity-id": "7529"}, {"#tail": "; the ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National Institutes of Diabetes and Digestive and Kidney\n\t\t\t Diseases", "@value": "National Institutes of Diabetes and Digestive and Kidney Diseases"}, {"#tail": "; the ", "@entity-type": "federal-body", "#text": "Eunice Kennedy Shriver National Institute of Child Health\n\t\t\t and Human Development", "@value": "Eunice Kennedy Shriver National Institute of Child Health and Human Development", "@entity-id": "7529"}, {"#tail": "; and the ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National Cancer Institute", "@value": "National Cancer Institute"}, {"#tail": "; and", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Office of\n\t\t\t Rare Diseases", "@value": "Office of Rare Diseases"}], "#text": "conducting or supporting basic, translational, and clinical research on HHT across the relevant\n\t\t\t national research institutes, national centers, and offices of the\n\t\t\t "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H3F3AE40632AF4DD8BCD38E7F29E0CC0B", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and the ", "@entity-type": "federal-body", "#text": "Director of the National\n\t\t\t Institutes of Health", "@entity-id": "7529"}, {"#tail": "\n\t\t\t regarding the prioritization and award of ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Director of the National Cancer Institute", "@value": "National Cancer Institute"}, {"#tail": "\n\t\t\t research grants relating to HHT, including with respect to grants for\u2014", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}], "#text": "conducting evaluations and making recommendations to the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "expanding understanding of HHT through basic, translational, and clinical research on the cause,\n\t\t\t diagnosis, prevention, control, and treatment of HHT;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HF8994087929D4284B9EBC260469A9EC2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "training programs on HHT for scientists and health professionals; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H33AFE355D8AF4A1A85359E9E580ABDDB", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "HHT genetic testing research to improve the accuracy of genetic testing."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HEFFE6F1691164D73818EF16D12F5D9FB", "#text": "\n                  "}], "#text": "\n                ", "@id": "HFEFB109877674CE0B9CC404B7CFBF84A"}]}], "#text": "\n            ", "@id": "HACC23A6FD16C485D8AD0089942C9D126"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "In this section:"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " established under ", "@entity-type": "federal-body", "@value": "HHT Coordinating Committee", "@entity-parent-id": "7500", "#text": "HHT Coordinating Committee"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Public Health Service Act/s:409K/ss:b", "@proposed": "true"}], "term": {"#tail": " means the ", "#text": "Committee"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HE61E4B1E08B34052AA9E140DB2613CA4", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "term": {"#tail": " means hereditary hemorrhagic telangiectasia.", "#text": "HHT"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H99065DCE90614AE5AD34BC4C95FB505E", "#text": "\n              "}], "#text": "\n            ", "@id": "H7E3D47B5041447B39524799229019F1E"}], "#text": "\n          ", "@id": "H35C57E302E334BD5BF1A578B5C07EA41"}, "#text": "\n\t\t\t\t", "@id": "HEAF1EE1B69A24536AD7B0FB0492FC248"}, "#text": "\n      ", "@id": "H0D1C7DEA8FB645708ABD669D26B880BE"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n\t\t\t", "#text": "Authorization of appropriations"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "$5,000,000 for each of fiscal years 2015 through 2019", "@amount": "5000000", "@year": "2015, 2016, 2017, 2018, 2019"}, "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ", there is authorized to be appropriated\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as added by ", "@entity-type": "act", "#text": "section 317U of the Public Health Service Act", "@value": "Public Health Service Act/s:317U", "@proposed": "true"}, {"#tail": ",\n\t\t\t ", "@entity-type": "act", "#text": "section 4 of this Act", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014/s:4", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "section 5 of this Act", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014/s:5", "@proposed": "true"}, {"#tail": "\n\t\t\t as added by ", "@entity-type": "act", "#text": "section 409K of the Public Health Service Act", "@value": "Public Health Service Act/s:409K", "@proposed": "true"}, {"#tail": "\n            ", "@entity-type": "act", "#text": "section 6 of this Act", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014/s:6", "@proposed": "true"}], "#text": "To carry out ", "@name": "purpose"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "#text": "\n        ", "@id": "H2BC98609732746D8A85532FE6CD40C46"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for each of fiscal years 2015\n\t\t\t through 2019, $1,000,000 shall be for carrying out ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014/s:7/ss:a", "@proposed": "true"}, {"#tail": ", as added by ", "@entity-type": "act", "#text": "section 317U(a)(4) of\n\t\t\t the Public Health Service Act", "@value": "Public Health Service Act/s:317U/ss:a/p:4", "@proposed": "true"}, {"#tail": "\n            .\n        ", "@entity-type": "act", "#text": "section 4 of this Act", "@value": "Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014/s:4", "@proposed": "true"}], "#text": "\n          Of the amount authorized to be appropriated under "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Resource center"}, "#text": "\n        ", "@id": "H6DAC80E36D624AD48C68EBD7BC6BFF29"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " ", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "{http://namespaces.cato.org/catoxml}property": {"#tail": " ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "federal-body", "#text": "Department", "@entity-id": "7500"}, "#text": "for salaries\n\t\t\t and expenses of the ", "@name": "purpose"}, "#tail": "\n        ", "@entity-type": "auth-auth-approp", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": " less than the amount appropriated for such\n\t\t\t salaries and expenses for fiscal year 2014.", "#text": "for each of fiscal years 2015 through 2019\n\t\t\t the amount that is $5,000,000", "@amount": "-5000000", "@year": "2015, 2016, 2017, 2018, 2019"}, "#text": "There is authorized to be appropriated to the "}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Offset"}, "#text": "\n        ", "@id": "HB08B58A892B1492CB66FC055B3FA8F80"}], "#text": "\n      ", "@id": "HDAD2DFCB74E4471F907FDC689A7E457E"}], "#text": "\n\t\t", "@id": "H0837E639E8874B40993A0DB8A86B7A49"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-05-07"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4592 IH: Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}